Shares of U.S. critical minerals companies MP Materials (NYSE:MP) and USA Rare Earth (NASDAQ:USAR) saw gains after President Donald Trump signed an executive order initiating a probe into the national ...

Tourism Holdings (ASX:THL) has provided a trading update for FY25, signalling a downgrade in performance expectations due to deteriorating global conditions and reduced consumer confidence. The ...

Challenger (ASX:CGF) reported solid performance in its Q3 FY25 results, with total life sales reaching $1.4 billion, supported by strong long-tenor annuity sales. The company saw a 22% increase in ...

Westpac (ASX:WBC) and Commonwealth Bank of Australia (ASX:CBA) are under fire from leading environmentalists over a $497 million sustainability-linked loan to Tassal, a Tasmanian salmon farming ...

Titomic (ASX:TTT) announced a collaboration with aerospace and defence giant Northrop Grumman to develop and manufacture high-performance pressure vessels. By combining Titomic's expertise in cold ...

StoneX Group (NASDAQ:SNEX) today announced a definitive agreement to acquire R.J. O’Brien (“RJO”), the oldest futures brokerage in the United States, for an approximate equity value of $900 million.

CSX Corp. (NASDAQ:CSX) today announced its financial results for the first quarter of 2025, reporting a decrease in both operating income and revenue compared to the same period last year. The railway ...

Mind Medicine (MindMed) (NASDAQ:MNMD), a biopharmaceutical company focused on developing treatments for brain health disorders, announced today the initiation of its Phase 3 Emerge study. The trial ...

Energy giant Valero (NASDAQ:VLO) announced today that it has recorded a significant $1.1 billion pre-tax impairment related to its California refining assets. The company also revealed its intention ...

The cryptocurrency market has experienced a significant downturn in 2025, with the total altcoin market capitalisation falling by $650 billion since December 2024, according to Coinbase’s April market ...

MetaVia (NASDAQ:MTVA), a biotechnology company focused on cardiometabolic diseases, today announced promising results from its Phase 1 clinical trial of DA-1726, a novel drug for the treatment of ...

Arthur Cheong, founder of DeFiance Capital, has raised concerns about the integrity of cryptocurrency markets, claiming that price manipulation by market makers and centralised exchanges (CEXs) is ...